Futura Medical shares rose 11% after a small trial showed its WSD4000 gel significantly improved female sexual function.

FDA accepts pimicotinib NDA for rare joint tumor, based on positive trial results.

Alamar Biosciences launches a blood test measuring five Alzheimer’s biomarkers for research use.

Boston Scientific to acquire Valencia Technologies for its FDA-approved eCoin device treating overactive bladder.

Taiwan's president announces $90M in subsidies for smart healthcare projects to improve medical efficiency and extend healthy lifespans.

Generic semaglutide may cut drug prices by 65% in Canada by spring 2026 after patent expiry.

A new AI tool predicts how brain tumor patients respond to diet and drugs by modeling real-time tumor metabolism, offering personalized treatment options.

Federal funding cuts are disrupting pediatric brain cancer research in 2026, delaying progress on treatments for a rare childhood disease.

China to launch 2026 pilot cloud system merging health, insurance data for personalized care and AI use.

Curiteva launched its new spinal implant system in January 2026, marking a major step in anterior spine surgery innovation.